The global cell culture market is anticipated to grow at a stupendous CAGR of approximately 11.9% throughout the forecast period from 2022 to 2032. The global market touched a valuation of around US$ 22 Billion in 2021 and is likely to reach US$ 43 Billion in 2026. The cell culture market is anticipated to surpass a valuation …
Category Archives: Healthcare Trends
North American Outbound Medical Tourism Services Market is projected to reach US$ 605.36 Billion by 2032 growing at a 25% CAGR
In 2022, it is expected that the North America Outbound Medical Tourism Services Market will exceed US$ 65.0 billion. By 2032, the North American Outbound Medical Tourism Services Market is projected to reach US$ 605.36 billion, growing at a 25% CAGR. According to a new report published by Future Market Insights titled “Outbound Medical Tourism …
Teleradiology Services Market is expected to surpass US$ 5,598.3 Million by 2032 grow at 19% CAGR
In 2022, it is expected that the Teleradiology Services Market would be worth around US$ 31,880.57 Mn. By 2032, it is anticipated that the market for teleradiology services would reach US$5,598.3 Mn. with a 19% CAGR growth forecast through 2032. The global Teleradiology Services Market is estimated to reach a market valuation of US$ 1,971.4 Mn by …
Positron Emission Tomography (PET) Scanners Market is expected to surpass US$ 2.1 Billion by 2033 grow at 5.3% CAGR
According to estimates, the Positron Emission Tomography (PET) Scanners Market will be worth US$ 1.3 billion in 2023 and US$ 2.1 billion by 2033. Throughout the forecast period, the market is anticipated to expand at a CAGR of 5.3%. The market for positron emission tomography (PET) scanners is driven by a number of variables, including: …
Europe Platelet Rich Plasma (PRP) Market size is estimated to cross US$ 84.10 Million by 2032 at a CAGR of 7%
In 2022, the Europe Platelet Rich Plasma (PRP) Market is anticipated to reach a value of US$42.75 million. The market for platelet-rich plasma in Europe is predicted to reach US$ 84.10 million by 2032, with a CAGR of 7% projected to be achieved during that time. The Europe Platelet Rich Plasma (PRP) Market is expected …
By 2032, the Market value of Hyperbaric Oxygen Therapy Devices is expected to reach US$ 6.37 Billion
The global Hyperbaric Oxygen Therapy Devices Market size is expected to be valued at US$ 3.21 Billion in 2022. With the growing usage of hyperbaric oxygen therapy in wound healing, coupled with the increasing number of athletes resulting in demand for HBOT, the overall demand for Hyperbaric Oxygen Therapy Devices is projected to grow at a CAGR …
Regenerative Artificial Skin Market is expected to reach a valuation of US$ 5,615.5 Million by 2032 | FMI
The global Regenerative Artificial Skin Market is expected to be valued at US$ 2,185.5 Million in 2022. This market is expanding because hospitals and clinics are increasingly in need of both temporary and permanent skin materials. The total demand for synthetic skin that is regenerative is anticipated to reach US$ 5,615.5 million in revenue by …
Mobile Cardiac Telemetry Systems Market is likely to grow to a valuation of US$ 2,872.05 Million by 2032 | FMI
The global Mobile Cardiac Telemetry Systems market will witness a stellar CAGR of 11.9% from 2022 to 2032. The target market will likely reach a valuation of US$ 2,872.05 million by 2032 as opposed to US$ 933.02 million in 2022. The rising incidences of cardiovascular disorders (CVDs) and associated mortality have generated greater awareness regarding …
HER2 Positive Gastric Cancer Market is predicted to reach a valuation of US$ 1779.8 Million by 2033
The global HER2 Positive Gastric Cancer Market is currently valued at US$ 1261.8 million in 2023, with a CAGR of 3.5% expected. Because of technological advancements in healthcare, the market is expected to reach US$ 1779.8 million by 2033. “Increased disease burden and pipeline candidate approval are likely to drive the growth of the HER2 …
Neurological Biomarkers Market is expected to reach a valuation of US$ 12.5 Billion by 2033 | FMI
The global Neurological Biomarkers Market is projected to have a high-paced CAGR of 4.6% during the forecast period. The current valuation of the neurological biomarkers market is US$ 8 Billion in 2023. The value of the neurological biomarkers market is anticipated to reach a high of US$ 12.5 Billion by the year 2033. The key …